Syngen Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 07, 2019 at 03:10 pm EDT
Share
Syngen Biotech Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 353.958 million compared to TWD 263.744 million a year ago. Operating income was TWD 75.268 million compared to TWD 43.154 million a year ago. Net income was TWD 58.874 million compared to TWD 27.790 million a year ago. Basic earnings per share was TWD 2.55 compared to TWD 1.2 a year ago. For the half year, sales was TWD 618.353 million compared to TWD 456.568 million a year ago. Operating income was TWD 116.501 million compared to TWD 57.729 million a year ago. Net income was TWD 92.536 million compared to TWD 42.673 million a year ago. Basic earnings per share was TWD 4.01 compared to TWD 1.85 a year ago. Diluted earnings per share was TWD 4 compared to TWD 1.85 a year ago.
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.
SYNGEN BIOTECH CO.,LTD. 
